Kevin Stevenson
Overview
Explore the profile of Kevin Stevenson including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
15
Citations
114
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Betancur M, Case A, Ilich E, Mehta N, Meehan S, Pogrebivsky S, et al.
Neurooncol Adv
. 2024 May;
6(1):vdae064.
PMID: 38813113
Background: A major hurdle to effectively treating glioblastoma (GBM) patients is the lack of longitudinal information about tumor progression, evolution, and treatment response. Methods: In this study, we report the...
2.
Hariharan S, Whitfield B, Pirozzi C, Waitkus M, Brown M, Bowie M, et al.
Nat Commun
. 2024 Jan;
15(1):730.
PMID: 38272925
Stimulating the innate immune system has been explored as a therapeutic option for the treatment of gliomas. Inactivating mutations in ATRX, defining molecular alterations in IDH-mutant astrocytomas, have been implicated...
3.
Thompson E, Kang K, Stevenson K, Zhang H, Gromeier M, Ashley D, et al.
Transl Oncol
. 2024 Jan;
40:101875.
PMID: 38183802
HSV G207, a double-stranded, DNA virus, and the polio:rhinovirus chimera, PVSRIPO, a single positive-strand RNA virus, are viral immunotherapies being used to treat pediatric malignant brain tumors in clinical trials....
4.
Jones J, Zhang H, Lyne A, Cavalli F, Hassen W, Stevenson K, et al.
Neurooncol Adv
. 2023 Oct;
5(1):vdad095.
PMID: 37781087
Background: Medulloblastoma is the most common malignant pediatric brain tumor, and leptomeningeal dissemination (LMD) of medulloblastoma both portends a poorer prognosis at diagnosis and is incurable at recurrence. The biological...
5.
Hariharan S, Whitfield B, Pirozzi C, Waitkus M, Brown M, Bowie M, et al.
bioRxiv
. 2023 May;
PMID: 37131619
Stimulating the innate immune system has been explored as a therapeutic option for the treatment of gliomas. Inactivating mutations in , defining molecular alterations in -mutant astrocytomas, have been implicated...
6.
Yang Y, Brown M, Zhang G, Stevenson K, Mohme M, Kornahrens R, et al.
Neuro Oncol
. 2023 Mar;
25(9):1631-1643.
PMID: 36864784
Background: Malignant gliomas commandeer dense inflammatory infiltrates with glioma-associated macrophages and microglia (GAMM) promoting immune suppression, evasion, and tumor progression. Like all cells in the mononuclear phagocytic system, GAMM constitutively...
7.
Leuthner T, Benzing L, Kohrn B, Bergemann C, Hipp M, Hershberger K, et al.
Nucleic Acids Res
. 2022 Aug;
50(15):8626-8642.
PMID: 35947695
Mitochondrial DNA (mtDNA) is prone to mutation in aging and over evolutionary time, yet the processes that regulate the accumulation of de novo mtDNA mutations and modulate mtDNA heteroplasmy are...
8.
Low J, Chandramohan V, Bowie M, Brown M, Waitkus M, Briley A, et al.
Cancer Cell
. 2022 Apr;
40(5):439-440.
PMID: 35487217
No abstract available.
9.
Stevenson K, Uversky V
J Biomol Struct Dyn
. 2019 Sep;
38(12):3730-3735.
PMID: 31524088
Communicated by Ramaswamy H. Sarma.
10.
Nemoto E, Mendez O, Kerr M, Firlik A, Stevenson K, Jovin T, et al.
Transl Stroke Res
. 2013 Dec;
3(3):369-74.
PMID: 24323812
Computerized tomography (CT) is the most often used imaging modality in the evaluation of acute clinical stroke. However, the rapidity with which CT density changes occur after acute, severe, focal...